Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 1.90B P/E - EPS this Y - Ern Qtrly Grth -6.20%
Income 408.5M Forward P/E - EPS next Y - 50D Avg Chg -10.00%
Sales 1.17B PEG - EPS past 5Y - 200D Avg Chg -10.00%
Dividend N/A Price/Book EPS next 5Y - 52W High Chg -32.00%
Recommedations - Quick Ratio 0.75 Shares Outstanding 57M 52W Low Chg 23.00%
Insider Own - ROA - Shares Float - Beta -
Inst Own - ROE - Shares Shorted/Prior -/- Price 33.33
Gross Margin 68.66% Profit Margin 34.94% Avg. Volume 3,478,730 Target Price -
Oper. Margin 41.31% Earnings Date - Volume 132,301 Change -9.33%
About Embecta Corp.

Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to wholesalers and distributors in the United States and internationally. Embecta Corp. was founded in 1924 and is based in Parsippany, New Jersey.